263193 What to expect, the first year: Infant bacterial colonization and resistance

Monday, October 29, 2012 : 11:05 AM - 11:20 AM

Sharon Meropol, MD, PhD , Department of Pediatrics and Department of Epidemiology and Biostatistics, Rainbow Babies and Children's Hospital, Cleveland, OH
Kurt C. Stange, MD, PhD , Family Medicine and Epidemiology and Biostatistics, Case Western Reserve University School of Medicine, Cleveland, OH
Michael R. Jacobs, MD, PhD , Pathology, Case Western Reserve University School of Medicine, Cleveland, OH
Judith K. Weiss, BA, MFA , Department of Family Medicine, Case Western Reserve University School of Medicine, Cleveland, OH
Saralee Bajaksouzian, MS , Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH
Robert A. Bonomo, MD , Stokes Cleveland Veterans Affairs Medical Center and Medicine, Case Western Reserve University School of Medicine, Cleveland, OH
Background: Newborns have sterile nasopharyngeal (NP) and GI tracts, yet young children are frequent antibiotic consumers and important reservoirs of antibiotic-resistant organisms. This creates an opportunity to study colonization and resistance from a microbiological tabula rasa. Objectives: To characterize longitudinal colonization with bacterial pathogens and associated antibiotic resistance from birth over the first 12 months of life, and their relationship with antibiotic and daycare exposure. Methods: In this ongoing study, 35 newborns enrolled, with interviews and NP, anterior nasal, and rectal swabs at 3-month intervals for 12 months, and cultured for S pneumoniae, S aureus, and extended spectrum beta lactamase (ESBL)-resistant gram negatives, respectively. Exposures are infant and household antibiotics and daycare. Outcomes are S pneumoniae and S aureus colonization and antibiotic resistance and ESBL. Results: We screened 35 infants' nursery and 19 3-month visits. 14/35 had perinatal or nursery antibiotic exposure. In the nursery, 0/35 infants were colonized with S pneumonia, 2 with S aureus (1 intermediate, 1 full erythromycin-resistance). By 3 months, 9/19 had antibiotic exposure, 11 personal or household exposure. 1 was colonized with S. pnemoniae (serotype 19A, penicillin, amoxicillin, azithromycin, clindamycin-resistant, intermediate cefotaxime-resistance) and 2 with S. aureus (erythromycin-resistant); both had household but not personal antibiotic exposure. The infant with S pneumoniae had perinatal antibiotic exposure and daycare. Those with S. aureus had perinatal antibiotics, not daycare. No ESBLs were identified. Conclusions: This pilot study quantifies antibiotic exposure and longitudinal resistance. Further follow-up and a larger sample could identify key areas for potential intervention to foster judicious antibiotic prescribing in infants.

Learning Areas:
Epidemiology

Learning Objectives:
Describe longitudinal colonization with bacterial pathogens and associated antibiotic resistance from birth over the first 12 months of life, and their relationship with infant and household antibiotic and daycare exposure.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: My scholarly activity and research has focused on outcomes of antibiotic use. I have received a federally funded grant and published several related manuscripts.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.